| MODERN TREATMENT FOLLOWED | NUMBER | PERCENTAGE |
| Biguanides + Sulfonamides | 96 | 29.45% |
| Insulin + Biguanides | 51 | 15.64% |
| Biguanides | 51 | 15.64% |
| Insulin + DPP-4 inhibitors/Biguanides | 50 | 15.34% |
| Insulin + Biguanides + Sulfonamides | 24 | 7.36% |
| DPP-4 inhibitors/Biguanides | 14 | 4.29% |
| Insulin alone | 11 | 3.37% |
| Sulfonamides alone | 10 | 3.07% |
| Exclusive dietetic | 10 | 3.07% |
| DPP4-inhibitors | 3 | 0.92% |
| Sulfonamides + DPP4-inhibitors/Biguanides | 2 | 0.61% |
| Insulin + Sulfonamides | 2 | 0.61% |
| Sulfonamides + DPP4 inhibitors | 1 | 0.31% |
| Insulin + DPP4 inhibitors | 1 | 0.31% |
| TOTAL | 326 | 100.00% |